Ticker: BCLI

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) has released its latest financial results for the quarter ended March 31, 2025. Here’s a concise overview of the key points and statistics from its income statement and operational developments. Financial Highlights: Net Loss: $2.864 million for Q...